Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium
Journal of Ocular Pharmacology and Therapeutics · 2024
DOI: 10.1089/jop.2024.0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Masamichi Fukuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kanazawa Medical University, Kahoku, Japan. Hauptthemen laut MEDLINE: Diclofenac, Quinolones, Epithelium, Corneal, Ophthalmic Solutions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study aimed to investigate the relationship between diclofenac sodium ophthalmic solution (DFNa) and corneal epithelial cell damage and to evaluate the preventive effect of rebamipide (RBM) on it.
Methods
DFNa, DFNa/preservative-free (PF), or 0.5% chlorobutanol (CB) solution was instilled into the conjunctival sac of a normal rabbit eye, and corneal resistance measurement (using a corneal resistance device [CRD]) was performed 120 min after the end of instillation. Then, fluorescent staining (FL), corneal tissue staining (hematoxylin and eosin [H&E]), and immunostaining (zona occlusion-1) were performed (RBM-untreated group). However, RBM was instilled into the eyes of another group of normal rabbits, followed by each of the solutions; 120 min after the end of instillation, all evaluations were performed for this group (RBM treatment group).
Results
Using the CRD method, in the RBM-untreated group, corneal resistance (CR; %) was found to be significantly reduced in DFNa (79.9 ± 19.4%), DFNa/PF (89.1 ± 17.3%), and 0.5% CB (83.8 ± 10.6%). In addition, DFNa and 0.5% CB solutions showed positive staining in the FL staining method. In the H&E staining method, some clear voids were observed in the outermost layer of the cornea using DFNa and 0.5% CB solutions. However, corneal epithelial damage was suppressed in the RBM treatment group. ZO-1 immunostaining in DFNa and 0.5% CB solutions revealed discontinuous localization of ZO-1 at the cell periphery.
Conclusions
RBM eye drops were effective in preventing corneal epithelial damage caused by DFNa eye drops, and CB was considered to be the main causative agent of this damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Kanazawa Medical University, Kahoku, Japan.
- Department of Pharmacology, Kanazawa Medical University, Kahoku, Japan.
ORCID-Profile: Masamichi Fukuda
Zitieren
APA
Fukuda, M., Kiyoi, T., Takeda, S., Sasaki, Y., Masuoka, T., Kubo, E., & Sasaki, H. (2024). Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0025
Vancouver
Fukuda M, Kiyoi T, Takeda S, Sasaki Y, Masuoka T, Kubo E, et al. Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0025
BibTeX
@article{Fukuda2024,
author = {Fukuda, Masamichi and Kiyoi, Takeshi and Takeda, Shun and Sasaki, Yu and Masuoka, Takayoshi and Kubo, Eri and Sasaki, Hiroshi},
title = {Preventative Effect of Topical Rebamipide Against Corneal Epithelium Disorders Caused by Diclofenac Sodium},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
doi = {10.1089/jop.2024.0025}
}
EUVIMED